S. Gee, On the coeliac affection, St. Bartholomew's Hospital Report, vol.24, pp.17-20, 1888.

J. H. Van-de-kamer, H. A. Weijers, and W. K. Dicke, Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease, Acta Paediatr, vol.42, pp.223-231, 1953.

J. Baron, Journal of Pediatric Gastroenterology and Nutrition, vol.27, p.397, 1998.

, The Jewish Chronicle, vol.25, 1998.

T. T. Macdonald, Professor Anne Fergusson (Anne Collee) 1941-1998, Journal of Pediatric Gastroenterology and Nutrition, vol.28, issue.3, p.9, 1999.

C. Cedric and S. Wilfrid, Walker Colin -The Inheritance of coeliac disease, 1959.

K. Martinf, AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease -Gastroenterology, vol.131, pp.1977-1980, 2006.

J. West, R. F. Logan, P. G. Hill, A. Lloyd, S. Lewis et al., Khaw KT -Seroprevakence, correlates, and characteristics of undetected coeliac disease in England GUT, vol.52, pp.960-965, 2003.

M. Mäki, K. Holm, V. Lipsanen, O. Hällström, M. Viander et al., Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease -Lancet, vol.338, pp.1350-1353, 1991.

S. Rashtak and J. A. Murray, MD -Celiac Disease in the Elderly Gastroenterol Clin North Am, vol.38, pp.433-446, 2009.

N. Gujral, J. Hugh, A. Freeman, and . Thomson, Celiac disease : Prevalence, diagnosis, pathogenesis and treatment World J Gastroenterok, vol.18, pp.6036-6059, 2012.

E. Lionetti and C. Catassi, New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment -Int Rev Immunol, vol.30, pp.219-250, 2011.

N. Gujral and H. J. Freeman, Thomson AB -Celiac disease : prevalence, diagnosis, pathogenesis and treatment -World J Gastroenterol, vol.18, pp.6036-59, 2012.

C. Catassi, S. Gatti, and A. Fasano, The new epidemiology of celiac disease, J Pediatr Gastroenterol Nutr, vol.59, issue.1, pp.7-9, 2014.

J. H. West, R. F. Logan, P. G. Hill, and K. T. Khaw, The iceberg of celiac disease: what is below the waterline?, Clin Gastroenterol Hepatol, vol.5, pp.59-62, 2007.

H. J. Freeman and A. Chopra, Michael Tom Clandinin, and Alan BR Thomson -Recent advances in celiac disease, vol.17, pp.2259-2272, 2011.

C. Dube, A. Rostom, R. Sy, A. Cranney, N. Saloojee et al., The prevalence of celiac disease in average-risk and at-risk western European populations: a systematic review, Gastroentrerology, vol.128, pp.57-67, 2005.

M. Ludvig, Sollid and Bana Jabri -Celiac disease and transglutaminase 2 : Model for posttraslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders -Curr Opin Immunol, vol.23, pp.732-740, 2011.

B. Jabri, Sollid LM Tissue-mediated control of immunopathology in coeliac disease, Nat Rev Immunol, vol.9, pp.858-870, 2009.

L. Maiuri, C. Ciacci, L. Vacca, I. Ricciardelli, S. Auricchio et al., Londel M -IL-15 drives the specific migration of CD94+ and TCR-gammadelta+ intraepithelial lymphocytes in organ cultures of treated celiac patients, Am J Gastroenterol, 2001.

S. Hüe, J. J. Mention, R. C. Minteiro, S. Zhang, C. Cellier et al., Caillat-Zucman S -A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease, Immunity, vol.21, issue.3, pp.367-77, 2004.

G. Terrazzano, Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization, J. Immunol, vol.179, pp.372-381, 2007.

V. Abadie, L. M. Sollid, L. B. Barreiro, and B. Jabri, Integration of genetic and immunological insights into a model of celiac disease pathogenesis, Annu Rev Immunol, 2011.

, Coeliac disease: dissecting a complex inflammatory disorder. Sollid LM Nat Rev Immunol, vol.2, pp.647-55, 2002.

M. Mäki, The humoral immune system in coeliac disease, Baillieres Clin Gastroenterol, vol.9, issue.2, pp.231-280, 1995.

M. Tamara, C. Moura, I. Arcos, M. Lebreton, C. Ben-khalifa et al., , vol.71

J. M. Barker and E. Liu, MD -Celiac Disease : pathophysiology, Clinical Manifestations and Associated Autoimmune Conditions, Adv Pediatr, vol.55, pp.349-365, 2008.

A. De-lecea, C. Ribes-koninckx, and I. Polanco, Serological screening (antigliadin and antiendomysium antibodies) for non-overt coeliac disease in children of short stature, Acta Paediatr Suppl, vol.412, pp.54-59, 1996.

S. I. Katz and W. Strober, The pathogenesis of dermatitis herpetiformis, J Invest Dermatol, vol.70, pp.63-68, 1978.

Y. Bouhnik and J. C. Rambaud, Manifestations systémiques associées à la maladie coeliaque de l'adulte, Gastroenterol Clin Biol, vol.15, pp.28-33, 1991.

B. Amal, B. Imane, E. Wafae, A. F. , A. Rajae et al., Essaid Abdellah -Maladie coeliaque et atteinte neurologique à propos de 13 cas

M. Urban-kowalczyk and O. Janusz, and Agnieszka Gmitrowicz -Neuropsychiatric symptoms and celiac disease, Neuropsycgiatr Di Treat, vol.10, pp.1961-1964, 2014.

D. Snatos, S. Lioté, and F. , Osteoarticular manifestations of celiac disease and non-celiac gluten hypersensitivity, Joint Bone Spine, vol.84, issue.3, pp.263-266, 2017.

M. Kehila, R. Ben-hmind, and I. Godcha, Hassine Saber Abouda, Oueslati Boujomaa et Mohamed Badis Chanoufi -La maladie coeliaque : une cause rare de fausses couches à répétition, Pan Afr Med J, vol.25, p.197, 2016.

A. S. Freedman, C. A. Jacobson, P. Mauch, J. C. Aster, V. T. Devita et al., Cancer: Principles and Practice of Oncology, vol.103, pp.1552-1583, 2015.

, HAS-Quelles recherches d'anticorps prescrire dans la maladie coeliaque, 2007.

, Item 282 -Campus Cerimes -Diarrhée chronique chez l'adulte et l'enfant consulté le 9 septembre, p.36, 2019.

D. Gaetani and M. , Villous Atrophy and Negative Celiac Serology : A Diagnostic and Therapeutic Dilemma, Am J Gastro, 2013.

G. Oberhuber and G. Granditsch, Vogelsang H -The histopathology of coeliac disease : time forme a standardized report scheme for pathologists -Eur, J Gastroenterol Hepatol, vol.11, issue.10, pp.1185-94, 1999.

K. Rostamo, J. Kerckhaert, R. Tiemessen, V. Blomberg, B. M. Mejier et al., Mulder CJ -Sensitivity of antiendomysium and antigliadin antibiodies in untreated celiac disease : disappointing in clinical practice, Am Gastroenterol, vol.94, issue.4, pp.888-94, 1999.

. Ke-evans and . Aziz, S Cross -A prospective study of duodenal bulb biopsy in newly diagnosed and established adult celiac disease, Am J Gastroenterol, 2011.

P. D. Howdle, P. K. Jalal, and G. K. Holmes, Primary small-bowel malignancy in the UK and its association with coeliac disease, QJM, vol.96, pp.345-353, 2003.

G. Malamut, V. Verkarre, and C. Callens, Enteropathy-associated T-cell lymphona complicating an autoimmune enteropathy, Gastroenterology April, vol.142, issue.4, pp.726-729, 2012.

L. Fadila, A. A. Nassima, C. Yazid, O. Rachid, C. Salima et al., Asselah Hocine -Maladie coeliaque et cancer : à propos de 9 cas, 2019.

C. Cellier, E. Delabesse, C. Helmer, N. Patey, C. Matuchansky et al., Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group, Lancet, vol.356, pp.203-211, 2000.

A. Doucet, G. Favre, and G. Deschênes, Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications, Pediatr Nephrol, vol.22, pp.1983-90, 2007.

. Ridascreen-®-gliadin,

«. Logo, . De, and . Barré, Association Of European Coeliac Societies -consulté le 10 juillet, 2019.

, DE LA COMMISSION du 20 janvier 2009 relatif à la composition et à l'étiquetage des denrées alimentaires convenant aux personnes souffrant d'une, 2009.

, AFDIAG -Nos missions et actions

, HAS -Education thérapeutique du patient -19 juin, 2014.

F. Boukezoula and M. , Zidoune -Observance du régime sans gluten et ses conséquences sur l'état nutrionnel et la santé chez 100 malades coeliaques à Tébessa

, Le remboursement des produits sans gluten

J. F. Ludvigsson, D. A. Leffler, J. C. Bai, F. Blagi, A. Fasano et al., Ciacci C -The Oslo definitions for ceoliac disease and related terms, Gut, vol.62, issue.1, pp.43-52, 2013.

G. C. Alfsen and K. Beiske, Marton PF -Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma : case report suggesting a possible histogenic relationship, Hum Pathol, vol.20, issue.9, pp.909-922, 1989.

D. J. Unsworth and D. L. Brown, Serological screening suggests that adult celiac disease is underdiagnosed in the UK and increases the incidence by up to 12 %, Gut, vol.35, pp.61-65, 1994.

M. Latorre and H. R. Peter, Green -The Role of Corticosteroids in celiac disease, vol.57, pp.3039-3041, 2012.

, INSERM -Inhibition du transport intestinal de peptides toxiques de la gliadine médiée par un récepteur dans la maladie coeliaque : vers de nouvelles voies thérapeutiques -consulté le 6 juillet 2019

, Nathalie Vergnolle -une protéine naturelle, l'Elafine contre l'intolérance au gluten ?, vol.8, 2014.

C. Klöck and R. Thomas, DiRaimondo and Chaitan Khosla -role of transglutaminase 2 in celiac disease pathogenesis -Semin Immunopathol, 2012.

J. Xia, M. Siegel, E. Bergseng, and M. Ludvig, Sollid and Chaitan Khosla -Inhibition of HLA-DQ2 Mediated Antigen Presentation by Analogues og a High Affinity 33-residue Peptide from ?2-Gliadin, J Am Chem Soc, vol.128, issue.6, pp.1859-1867, 2006.

N. Rawal, M. Md, W. Twaddell, A. Md, . Fasano et al., Remission of refractory celiac disease with infliximab in a pediatric patient -ACG Case Rep J, vol.2, pp.121-123, 2015.

C. J. Van-der-woude, P. Stokkers, A. A. Van-bodegraven, G. Van-assche, Z. Hebzda et al., Phase I, double-blind, randomized, placebo-controlled, doseescalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease, Inflamm Bowel Dis, vol.16, issue.10, pp.1708-1716, 2010.

J. Edwards, L. Szczepanski, J. Szechinski, A. Filipowicz-sosnowska, P. Emery et al., Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis, N Engl J Med, vol.350, issue.25, pp.2572-2581, 2004.

J. L. Mccarville, A. Caminero, and F. Elena, Verdu -Celiac Treatments, Adjuvant Therapies and Alternatives to the Gluten-Free Diet, Advances in the Understanding of gluten Related Pathology and the Evolution of Gluten-Free Foods, pp.223-253, 2015.

S. Sánchez-león, J. Gil-humanes, and C. V. Ozuna, Low-gluten, non-transgenic wheat engineered with CRISPR/Cas9, Plant Biotechnology Journal, 2017.

N. Asmar, C. Cellier, S. Khater, A. Trinquand, L. Lhermitte et al., Malamut -Le budésonide est efficace dans les atteintes hépatiques de la Sprue coeliaque réfractaire -consulté le 5 novembre, 2019.

J. König, S. Holster, J. Maaike, and R. J. Bruins, Brummer -Randomized clinical trial : Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting, Front. Pediatr, vol.14, 2019.

M. T. Bethune, P. Strop, Y. Tang, L. M. Sollid, and C. Khosla, Heterologous expression, purification, refolding, and structural-functional characterization of EP-B2, a selfactivating barley cysteine endoprotease, Chem Biol, vol.136, pp.637-684, 2006.

M. L. Lähdeaho, K. Kaukinem, K. Laurila, P. Vuotikka, O. P. Koivurova et al., ALV0à3 attenuates gluten-induced mucosal injury in patients with celiac disease, Gastroenterology, vol.146, issue.7, pp.1649-58, 2014.

, Biomed -un brevet pour le premier traitement de l'intolérance au gluten, vol.25, pp.515-526, 2014.

, Innovate biopharmaceuticals -Larazotide INN-202 -consulté le 20 septembre 2019

K. Gottlieb, J. Dawson, F. Hussain, and A. Joseph, Murray -Development of drugs for celiac disease : review of endopoints for Phase 2 and 3 trials, Gastroenterology Report, vol.3, issue.2, pp.91-102, 2015.

J. Groese and S. T. Gaze, loukas A -Changed gluten immunity in celiac disease by Necator americanus provides new insights into autoimmunity, Int J Parasitol, vol.43, issue.3-4, pp.275-82, 2013.

, Safety and tolerability, immunological and intestinal effects, and pharmacokinetics (PK) of dose titration preceding maintenance doses of Nexvax2® in HLA-DQ2.5+ celiac disease (CeD)

M. Treohan, R. Cooreman, and . Anderson, Presentation Number, vol.118

A. Justin-l-mccarville and . Caminero, Elena F Verdu -Pharmacological approaches in celiac disease -Curr Opin Pharmacol, vol.25, pp.7-12, 2015.

L. C. Stene, M. C. Honeyman, E. J. Hoffenberg, J. E. Haas, S. Rj et al., Rewers M -Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood : a longitudinal study, Am Gastroenterol, vol.101, issue.10, pp.2333-2373, 2006.

. Dr and . Benjamin, Lebwohl -Celiac disease Risk Linked to Proton Pump Inhibitor Medication, vol.46, pp.36-40, 2014.

L. Rcp-ansm--consulté, , 2019.

T. H. Tran, C. Smith, and R. A. Mangione, Drug absorption in celiac disease, Am J Health Syst Pharm, vol.70, issue.24, pp.2199-206, 2013.

J. P. Mcfadden, N. Leonard, A. V. Powles, and L. Fry, Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid, Br J Dermatol, vol.121, issue.6, pp.759-62, 1989.

C. P. Kelly, Advances in Diagnosis and Management of Celiac Disease

, Gastroenterology, vol.148, issue.6, pp.1175-86, 2015.